Clinical implications of fatty pancreas: Correlations between fatty pancreas and metabolic syndrome

Table 1 Clinical and laboratory characteristics of study groups

	Non-fatty pancreas (n = 113)	Fatty pancreas (n = 180)	P-value
Age (yr)	44.4 ± 9.7	45.4 ± 8.5	NS
Sex (male/female)	34/79	93/87	< 0.001
BMI (kg/m2)	24.4 ± 3.2	26.5 ± 3.1	< 0.001
WC (cm)	82.1 ± 9.3	88.9 ± 8.5	< 0.001
Visceral Fat(mm2)	7462 ± 3244	10767 ± 4260	< 0.001
AST (IU/L)	23.8 ± 11.1	30.2 ± 20.7	0.001
ALT (IU/L)	25.0 ± 23.0	40.3 ± 32.2	< 0.001
FBS (mg/dL)	99.7 ± 24.0	102.9 ± 26.2	NS
TC (mg/dL)	192.9 ± 36.4	205.2 ± 35.2	0.005
TG (mg/dL)	119.6 ± 70.3	159.8 ± 92.5	< 0.001
LDL (mg/dL)	118.6 ± 36.3	124.8 ± 27.4	NS
HDL (mg/dL)	51.9 ± 10.1	47.7 ± 10.6	0.001
γ-GT (mg/dL)	29.9 ± 29.9	46.5 ± 43.0	< 0.001
Fasting insulin (&mgr;U/mL)	5.4 ± 2.1	6.8 ± 3.6	< 0.001
HOMR-IR	2.3 ± 1.0	3.2 ± 2.1	< 0.001
FFA (mg/dL)	639.3 ± 287.6	767.9 ± 324.9	0.001

P < 0.05 by t-test; NS: Not significant; BMI: Body mass index; WC: Waist circumference; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; FBS: Fasting blood sugar; TC: Total cholesterol; TG: Triglyceride; HDL: High density lipoprotein cholesterol; LDL: Low density lipoprotein cholesterol; γ-GT: Gamma glutamyl transpeptidase; FFA: Free fatty acid.